Built to push human recovery forward.

Myodot was founded on a simple conviction: the neuromuscular system is the bridge between intention and motion, and yet it remains the least understood signal in modern recovery science.

We are building a complete tracking ecosystem — purpose-built for elite athletes, clinical rehabilitation teams, and biomedical researchers who need objective, longitudinal data to make decisions that change lives.

Our hardware is in the final stages of design and validation, with patents pending. We are launching publicly in December 2026, with a limited clinical-beta cohort opening in Q3 2026.